Senior Reimbursement & Access Manager

Xeris Pharmaceuticals, Inc.; Kentucky; Vor Ort; USD 104.000 - 166.000; Vollzeit

Zusammenfassung

Xeris Pharmaceuticals, Inc. is seeking a Reimbursement Access Manager II to lead initiatives ensuring timely access to rare disease therapies in the United States. The role involves addressing reimbursement challenges and collaborating across functions to enhance payer strategy execution.

The ideal candidate has deep rare disease market dynamics knowledge, strong U.S. reimbursement systems experience, and a passion for improving patient outcomes.

Qualifikationen

• Bachelor's degree required; advanced degree in health policy, business, or life sciences a plus.
• 5+ years of experience in pharmaceutical/biotech market access or reimbursement roles, preferably with rare diseases or specialty products.
• Strong understanding of U.S. healthcare reimbursement systems including Medicare, Medicaid, and commercial payers.

Aufgaben

• Serve as SME on reimbursement and access issues for rare disease products.
• Develop and execute strategies to overcome reimbursement and access barriers at patient and provider levels.
• Partner with field teams to provide reimbursement education and support to healthcare providers.
• Manage relationships with specialty pharmacy partners to ensure patient access.
• Track and analyze reimbursement trends, payer policy changes, and competitive landscape.

Kenntnisse

Reimbursement expertise

Cross-functional collaboration

Communication skills

Market access knowledge

Travel readiness

Ausbildung

Bachelor's degree

Advanced degree preferred

Tools

HUB services

Payer policies

Specialty pharmacies

Patient support programs

Jobbeschreibung

Xeris Pharmaceuticals, Inc. is seeking a Reimbursement Access Manager II to lead initiatives ensuring timely access to rare disease therapies in the United States. The role involves addressing reimbursement challenges and collaborating across functions to enhance payer strategy execution.

The ideal candidate has deep rare disease market dynamics knowledge, strong U.S. reimbursement systems experience, and a passion for improving patient outcomes.